Arkolith/Insider Trading/NMTR/Form 4

Sensenig Bethany

Chief Financial Officer9 METERS BIOPHARMA, INC. (NMTR) · full profile →Form 4 · filed Apr 21, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11K
Net Open-Market Flow
-$11K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 21, 2023Sell(S)9K$1.21$11K41K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001551986-23-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML